Search Results

Press Releases

Walgreens Boots Alliance Reports Fiscal 2025 First Quarter Results

January 10, 2025

·

19 min read

Bio NC

Mycovia Pharmaceuticals, Inc. Announces AllianceRx Walgreens Pharmacy and Walgreens Community-based Specialty Pharmacies as Exclusive Distributor of VIVJOA®

Mycovia Pharmaceuticals, Inc., an emerging biopharmaceutical company, announced that patients now have exclusive access to VIVJOA® through AllianceRx Walgreens Pharmacy and Walgreens community-based specialty pharmacies, subsidiaries of Walgreens Boots Alliance, Inc.

March 26, 2024

·

5 min read

Press Releases

Walgreens Boots Alliance Suspends Quarterly Dividend as Company Continues Disciplined Execution Against Strategic Priorities

January 30, 2025

·

3 min read

Business

Walgreens and Boehringer Ingelheim Are Partnering to Improve Diversity in Clinical Trials

Walgreens and Boehringer Ingelheim announced a strategic collaboration aimed at optimizing recruitment and making clinical trials more accessible, inclusive and equitable.

May 2, 2024

·

6 min read

Press Releases

Walgreens Launches Inaugural Patient Advisory Board to Advance Access and Representation in Clinical Research

December 13, 2024

·

3 min read

Press Releases

Walgreens Boots Alliance Adjusts Fiscal 2025 First Quarter Earnings Announcement to be Held on January 10

January 2, 2025

·

1 min read

Pictured: Boehringer Ingelheim's office in California

Drug Development

Boehringer, Walgreens Team Up for Obesity Trial as Weight-Loss Drug Race Heats Up

In an effort to improve diversity and accessibility in clinical trials, Boehringer Ingelheim is partnering with Walgreens to conduct a Phase III study in obesity and type 2 diabetes.

May 3, 2024

·

2 min read

·

Tristan Manalac

Deals

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance

Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $400 million in a private transaction.

May 22, 2024

·

3 min read

Decentralized trials

Walgreens, BARDA Team in $100M Partnership to Boost Decentralized Clinical Trials

The retail pharmacy giant and the Biomedical Advanced Research and Development Authority hope to make decentralized clinical trials more accessible and representative of the U.S. population.

August 20, 2024

·

2 min read

·

Tristan Manalac

Business

Walgreens Boots Alliance Reports Fiscal 2024 First Quarter Results

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the first quarter of fiscal 2024, which ended November 30, 2023.

January 4, 2024

·

37 min read